Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00642889
What this trial is testing

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 227
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Study completedNCT00866502
What this trial is testing

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Sweden AB 12
Large-scale testing (Phase 3)Study completedNCT03881371
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Who this might be right for
Parkinson Disease
Zambon SpA 307
Testing effectiveness (Phase 2)Study completedNCT01777555
What this trial is testing

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 89
Not applicableStudy completedNCT03700684
What this trial is testing

Voice Treatment for Parkinson's Disease

Who this might be right for
Idiopathic Parkinson Disease
University of Massachusetts, Amherst 36
Large-scale testing (Phase 3)Study completedNCT00242008
What this trial is testing

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma
Not applicableStudy completedNCT03156647
What this trial is testing

Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Centre Hospitalier Universitaire de Nīmes 80
Testing effectiveness (Phase 2)Study completedNCT01683292
What this trial is testing

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
South Glasgow University Hospitals NHS Trust 29
Not applicableActive Not RecruitingNCT07729748
What this trial is testing

Predicting Parkinson's Disease Before It Strikes: A Brain Imaging Study in At-Risk Individual

Who this might be right for
Idiopathic REM Sleep Behavior DisorderParkinson DiseaseNeurodegeneration+1 more
IRCCS San Raffaele 100
Not applicableStudy completedNCT01246336
What this trial is testing

Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath

Who this might be right for
Parkinson's DiseaseParkinsonism
Rambam Health Care Campus 41
Very early researchStudy completedNCT02879136
What this trial is testing

TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Who this might be right for
Parkinson's Disease, Idiopathic
Hubert Fernandez 23
Not applicableNot Yet RecruitingNCT07094828
What this trial is testing

Integration of Augmented Visual Feedback in Action Observation and Motor Imagery Therapy for Parkinson's Disease

Who this might be right for
Parkinson Disease, Idiopathic
University of Bergamo 86
Not applicableStudy completedNCT02627664
What this trial is testing

Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Lille 70
Early research (Phase 1)Study completedNCT02565628
What this trial is testing

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Pfizer 20
Not applicableEnrolling By InvitationNCT06872203
What this trial is testing

LFP Sensing From Directional Leads in the Acute Clinical Setting

Who this might be right for
Parkinson Disease, IdiopathicParkinson Disease
University of Colorado, Denver 10
Early research (Phase 1)Study completedNCT00115427
What this trial is testing

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Amgen
Large-scale testing (Phase 3)Ended earlyNCT01028586
What this trial is testing

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 507
Early research (Phase 1)Looking for participantsNCT07195825
What this trial is testing

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

Who this might be right for
PD
Shanghai Xinzhi BioMed Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03775538
What this trial is testing

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

Who this might be right for
Parkinson DiseaseMovement DisordersNeuro-Degenerative Disease+2 more
Herantis Pharma Plc. 15
Next Page